H1 Launches Gen AI Tool to Accelerate Clinical Trials
H1, a leading healthcare information source, unveiled GenosAI, a generative AI tool integrated into its clinical trial platform, Trial Landscape. GenosAI streamlines complex inquiries, aiding sponsors in finding new sites, assessing patient recruitment strategies, and analyzing competition. Deloitte estimates it can reduce drug discovery costs by 70%. GenosAI empowers clinical researchers with advanced data analysis, speeding up decision-making and improving efficiency. It draws insights from 490,000 trials, 25 million publications, 10 million healthcare providers, 240 million patients, and 11 billion claims, offering natural language query responses akin to ChatGPT. CEO Ariel Katz believes GenosAI will revolutionize clinical trials, boosting diversity and efficacy.
Make faster decisions with community advice
- AI Gets Better At Writing Patient Histories When Physicians Engineer The Prompts
- New Study Evaluates Virtual Reality to Reduce Scanxiety in Brain Tumor Patients
- Revolutionizing Healthcare: Harnessing the Power of IoT Solutions for Improved Patient Outcomes
- Carrum Health Raises $45 Million Series B to Expand Cancer Care Offerings and Launch New Service Lines
- Ethical Guardrails Are Essential To Making Generative AI Work For Healthcare
Deploy this technology today
-
nQ Cortex
Matched with Medical Subject Headings (MeSH): Biomedical Technology, Healthcare IT News: Artificial Intelligence
- NLabviva Platform
- Labviva Platform
- AI Dermatologist Platform
- Armis Platform for Healthcare